A Phase III, Randomized, Double-blind, Placebo-controlled, Multinational Trial of Iseganan for the Prevention of Oral Mucositis in Patients Receiving Stomatotoxic Chemotherapy (PROMPT-CT Trial)-Reference-Cited by-同舟云学术

A Phase III, Randomized, Double-blind, Placebo-controlled, Multinational Trial of Iseganan for the Prevention of Oral Mucositis in Patients Receiving Stomatotoxic Chemotherapy (PROMPT-CT Trial)

Published:2003-07 Issue:7 Volume:44 Page:1165-1172
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Giles Francis J.,Miller Carole B.,Hurd David D.,Wingard John R.,Fleming Thomas R.,Sonis Stephen T.,Bradford Williamson Z.,Pulliam Janis G.,Anaissie Elias J.,Beveridge Roy A.,Brunvand Mark M.,Martin Paul J.,PROMPT-CT Trial Investigators†

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/1042819031000079159

Reference42 articles.

1. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy

2. Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer

3. Stomatotoxic manifestations of cancer chemotherapy

4. Quantitative analysis of the oral complications of antileukemia chemotherapy

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cathelicidins—a rich seam of antimicrobial peptides waiting for exploitation;Frontiers in Drug Discovery;2024-09-06

2. A Review of Antibacterial Candidates with New Modes of Action;ACS Infectious Diseases;2024-07-17

3. Novel Antimicrobial Peptides Based on Protegrin-1: In Silico and in Vitro Assessments;2024

4. Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck;Cancer;2023-09-08

5. Design of Protegrin-1 Analogs with Improved Antibacterial Selectivity;Pharmaceutics;2023-07-30